The Medical City

The trials here

What the 14 trials at this site are about, from their registry records.

Conditions

• Stroke3 trials
• Liver and biliary tract cancer2 trials
• Lung cancer2 trials
• Acute myeloid leukaemia1 trial
• Atrial fibrillation1 trial
• Chronic kidney disease1 trial
• Coronary artery disease1 trial
• Head and neck cancer1 trial
• High blood pressure1 trial
• Lupus (SLE)1 trial
• Ovarian cancer1 trial
• Type 2 diabetes1 trial

Phase

• Phase 39 trials
• Phase 11 trial
• Phase 2/31 trial

Status

• Completed6 trials
• Active, not recruiting5 trials
• Recruiting2 trials
• Not yet recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Biogen1 trial
• Boehringer Ingelheim1 trial
• Eli Lilly and Company1 trial
• GenVivo, Inc.1 trial
• and 8 more

Running trials

• Recruiting

  A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

  NCT07241390· Phase 3· Eli Lilly and Company· Source

  Contact: Michelangelo Sabas (principal investigator)

• Recruiting

  Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

  NCT07007312· Phase 3· Kura Oncology, Inc.· Source

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)

  NCT05973773· Phase 3· Taiho Oncology, Inc.· Source

• Active, not recruiting

  A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

  NCT05702034· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

  NCT05531565· Phase 2/3· Biogen· Source

• Recruiting

  JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  NCT04892173· Phase 3· Johnson & Johnson Enterprise Innovation Inc.· Source

• Active, not recruiting

  A Study of Atezolizumab With Lenvatinib or Sorafenib Versus Lenvatinib or Sorafenib Alone in Hepatocellular Carcinoma Previously Treated With Atezolizumab and Bevacizumab

  NCT04770896· Phase 3· Hoffmann-La Roche· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Chronic kidney disease1 recruiting
• High blood pressure1 recruiting
• Stroke1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

  NCT05754957· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  Philippine Neurological Association One Database - Stroke

  NCT04972058· Philippine Neurological Association· Source

• Completed

  Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer

  NCT04205812· Phase 3· Incyte Corporation· Source

• Completed

  Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy

  NCT03837327· Venn Biosciences Corporation· Source

• Completed

  Cryo Global Registry

  NCT02752737· Medtronic Cardiac Ablation Solutions· Source

• Completed

  GEN2 Directed Cancer Immunotherapy Trial

  NCT04313868· Phase 1· GenVivo, Inc.· Source